Gesa Riedewald is the managing director of Kalapa Deutschland GmbH, a subsidiary of Kalapa Clinic, Spain.

She has already been working in the cannabis industry since 2017: first as a long-standing editor and patient advocate at Leafly, the knowledge portal on the topic of medical cannabis, and then at CanPharma, a pharmaceutical branded cannabis company.

Gesa Riedewald has experience in the healthcare, PR and communications industries.